Frailty risk increases with prediabetes among older adults suffering from hypertension, indicating a significant health concern.
Older adults with both prediabetes and hypertension exhibit a pronounced risk of frailty, suggesting a potential intervention avenue.
Assessment of frailty risk involved a thorough analysis of metabolic conditions linked to cardiovascular health among the elderly population in the study framework. The trial findings highlight the impactful role of metformin in mitigating frailty risk, underscoring the need for tailored treatment strategies.
Abstract
Prediabetes has garnered increasing attention due to its association with cardiovascular conditions, especially hypertension, which heightens the risk of prefrailty and frailty among older individuals.